|
1
|
Sugalski AJ, Jiwani A, Ketchum NS, Cornell
J, Williams R, Heim-Hall J, Hung JY and Langevin AM:
Characterization of localized osteosarcoma of the extremity in
children, adolescents, and young adults from a single institution
in South Texas. J Pediatr Hematol Oncol. 36:e353–e358. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bleyer A, O'Leary M, Barr R and Ries LAG:
Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29
Years of Age, Including SEER Incidence and Survival: 1975-2000. NIH
Pub. No 06-5767. National Cancer Institute. (Bethesda, MD).
2006.
|
|
4
|
Hagleitner MM, Hoogerbrugge PM, van der
Graaf WT, Flucke U, Schreuder HW and te Loo DM: Age as prognostic
factor in patients with osteosarcoma. Bone. 49:1173–1177. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bielack SS, Kempf-Bielack B, Delling G,
Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M,
Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma
of the extremities or trunk: An analysis of 1,702 patients treated
on neoadjuvant cooperative osteosarcoma study group protocols. J
Clin Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bacci G, Longhi A, Versari M, Mercuri M,
Briccoli A and Picci P: Prognostic factors for osteosarcoma of the
extremity treated with neoadjuvant chemotherapy: 15-year experience
in 789 patients treated at a single institution. Cancer.
106:1154–1161. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Whelan JS, Jinks RC, McTiernan A, Sydes
MR, Hook JM, Trani L, Uscinska B, Bramwell V, Lewis IJ, Nooij MA,
et al: Survival from high-grade localised extremity osteosarcoma:
Combined results and prognostic factors from three European
Osteosarcoma Intergroup randomised controlled trials. Ann Oncol.
23:1607–1616. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kelly AD, Haibe-Kains B, Janeway KA, Hill
KE, Howe E, Goldsmith J, Kurek K, Perez-Atayde AR, Francoeur N, Fan
JB, et al: MicroRNA paraffin-based studies in osteosarcoma reveal
reproducible independent prognostic profiles at 14q32. Genome Med.
5:22013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Diboun I, Wernisch L, Orengo CA and
Koltzenburg M: Microarray analysis after RNA amplification can
detect pronounced differences in gene expression using limma. BMC
Genomics. 7:2522006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wickham H; ggplot2, : Elegant graphics for
data analysis. Springer-Verlag. (New York, NY). 2016.
|
|
12
|
Scardoni G, Petterlini M and Laudanna C:
Analyzing biological network parameters with CentiScaPe.
Bioinformatics. 25:2857–2859. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eldeeb MA and Fahlman RP: The
anti-apoptotic form of tyrosine kinase Lyn that is generated by
proteolysis is degraded by the N-end rule pathway. Oncotarget.
5:2714–2722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang G, Lin RK, Kwon YT and Li YP:
Signaling mechanism of tumor cell-induced up-regulation of E3
ubiquitin ligase UBR2. FASEB J. 27:2893–2901. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin TY, Lee CC, Chen KC, Lin CJ and Shih
CM: Inhibition of RNA transportation induces glioma cell apoptosis
via downregulation of RanGAP1 expression. Chem Biol Interact.
232:49–57. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mao J, Liang Z, Zhang B, Yang H, Li X, Fu
H, Zhang X, Yan Y, Xu W and Qian H: UBR2 enriched in p53 deficient
mouse bone marrow mesenchymal stem cell-exosome promoted gastric
cancer progression via Wnt/beta-catenin pathway. Stem Cells.
35:2267–2279. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guan GG, Wang WB, Lei BX, Wang QL, Wu L,
Fu ZM, Zhou FX and Zhou YF: UBE2D3 is a positive prognostic factor
and is negatively correlated with hTERT expression in esophageal
cancer. Oncol Lett. 9:1567–1574. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang W, Yang L, Hu L, Li F, Ren L, Yu H,
Liu Y, Xia L, Lei H, Liao Z, et al: Inhibition of UBE2D3 expression
attenuates radiosensitivity of MCF-7 human breast cancer cells by
increasing hTERT expression and activity. PLoS One. 8:e646602013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao X, Wang W, Yang H, Wu L, He Z, Zhou S,
Zhao H, Fu Z, Zhou F and Zhou Y: UBE2D3 gene overexpression
increases radiosensitivity of EC109 esophageal cancer cells in
vitro and in vivo 7. 32543–32553. 2016.PubMed/NCBI
|
|
21
|
Liu S and Feng P: MiR-203 determines poor
outcome and suppresses tumor growth by targeting TBK1 in
osteosarcoma. Cell Physiol Biochem. 37:1956–1966. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang F, Yang Z, Cao M, Xu Y, Li J, Chen
X, Gao Z, Xin J, Zhou S, Zhou Z, et al: MiR-203 suppresses tumor
growth and invasion and down-regulates MiR-21 expression through
repressing Ran in esophageal cancer. Cancer Lett. 342:121–129.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Krichevsky AM and Gabriely G: miR-21: A
small multi-faceted RNA. J Cell Mol Med. 13:39–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ikenaga N, Ohuchida K, Mizumoto K, Yu J,
Kayashima T, Sakai H, Fujita H, Nakata K and Tanaka M: MicroRNA-203
expression as a new prognostic marker of pancreatic adenocarcinoma.
Ann Surg Oncol. 17:3120–3128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kunz M and Ibrahim SM: Molecular responses
to hypoxia in tumor cells. Mol Cancer. 2:232003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo M, Cai C, Zhao G, Qiu X, Zhao H, Ma Q,
Tian L, Li X, Hu Y and Liao B: Hypoxia promotes migration and
induces CXCR4 expression via HIF-1alpha activation in human
osteosarcoma. PLoS One. 9:e905182014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guan G, Zhang Y, Lu Y, Liu L, Shi D, Wen
Y, Yang L, Ma Q, Liu T, Zhu X, et al: The HIF-1alpha/CXCR4 pathway
supports hypoxia-induced metastasis of human osteosarcoma cells.
Cancer Lett. 357:254–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao J, Wang Y, Dong R, Lin G, Zhang N,
Wang J, Lin N, Gu Y, Ding L, Ying M, et al: Hypoxia-Induced WSB1
promotes the metastatic potential of osteosarcoma cells. Cancer
Res. 75:4839–4851. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shan K, Pang R, Zhao C, Liu X, Gao W,
Zhang J, Zhao D, Wang Y and Qiu W: IL-17-triggered downregulation
of miR-497 results in high HIF-1alpha expression and consequent
IL-1beta and IL-6 production by astrocytes in EAE mice. Cell Mol
Immunol. 2017. View Article : Google Scholar :
|
|
30
|
Wu Z, Cai X, Huang C, Xu J and Liu A:
miR-497 suppresses angiogenesis in breast carcinoma by targeting
HIF-1alpha. Oncol Rep. 35:1696–16702. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hoffmann EK and Lambert IH: Ion channels
and transporters in the development of drug resistance in cancer
cells. Philos Trans R Soc Lond B Biol Sci. 369:201301092014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Weaver AK, Liu X and Sontheimer H: Role
for calcium-activated potassium channels (BK) in growth control of
human malignant glioma cells. J Neurosci Res. 78:224–234. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Urrego D, Tomczak AP, Zahed F, Stühmer W
and Pardo LA: Potassium channels in cell cycle and cell
proliferation. Philos Trans R Soc Lond B Biol Sci.
369:201300942014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bloch M, Ousingsawat J, Simon R, Schraml
P, Gasser TC, Mihatsch MJ, Kunzelmann K and Bubendorf L: KCNMA1
gene amplification promotes tumor cell proliferation in human
prostate cancer. Oncogene. 26:2525–2534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Oeggerli M, Tian Y, Ruiz C, Wijker B,
Sauter G, Obermann E, Güth U, Zlobec I, Sausbier M, Kunzelmann K
and Bubendorf L: Role of KCNMA1 in breast cancer. PLoS One.
7:e416642012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bury M, Girault A, Mégalizzi V,
Spiegl-Kreinecker S, Mathieu V, Berger W, Evidente A, Kornienko A,
Gailly P, Vandier C and Kiss R: Ophiobolin A induces
paraptosis-like cell death in human glioblastoma cells by
decreasing BKCa channel activity. Cell Death Dis. 4:e5612013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cambien B, Rezzonico R, Vitale S,
Rouzaire-Dubois B, Dubois JM, Barthel R, Soilihi BK, Mograbi B,
Schmid-Alliana A and Schmid-Antomarchi H: Silencing of hSlo
potassium channels in human osteosarcoma cells promotes
tumorigenesis. Int J Cancer. 123:365–371. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Khaitan D, Sankpal UT, Weksler B, Meister
EA, Romero IA, Couraud PO and Ningaraj NS: Role of KCNMA1 gene in
breast cancer invasion and metastasis to brain. BMC Cancer.
9:2582009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sontheimer H: An unexpected role for ion
channels in brain tumor metastasis. Exp Biol Med (Maywood).
233:779–791. 2008. View Article : Google Scholar : PubMed/NCBI
|
